Sharechat Logo

TruScreen Group Limited (NZX: TRU) Board Appointment

Tuesday 2nd March 2021

Text too small?

TruScreen Board Appointment

• Fisher & Paykel Healthcare’s Dr Dexter Cheung joins as Non-Executive Director

• Mr Chris Lawrence retires

Truscreen Group Limited (TruScreen or Company) is pleased to announce the appointment of Dr. Dexter Cheung as a non-executive director of TruScreen.

Dr. Cheung is an experienced medical device engineer and specialist in product research and development, with more than 20 years’ experience. He is the Research & Development Manager of the respiratory humidification division of Fisher & Paykel Healthcare, an NZX/ASX listed healthcare company and a global leader in respiratory medical devices.

Dr Cheung’s technical background in opto-electronics and expertise in medical device engineering is highly relevant to TruScreen whose cervical cancer screening device harnesses optical and electrical signatures for screening results.

Dr. Cheung holds a first-class honours degree in Bachelor of Technology, a Master of Engineering (first class honours) degree and a Doctor of Philosophy (in physics) from his alma mater, University of Auckland.

Mr. Chris Lawrence has also announced his retirement from the board due to health reasons. Shareholders would recall that Mr. Lawrence was unable to attend the last annual shareholders general meeting in August 2020 for health reasons.

Tony Ho, Chairman commented “On behalf of the board, I thank Chris Lawrence for his unstinting contributions to the board over the past four years.

Please see the link below for details:

TruScreen Board Appointment

Source: TruScreen Group Limited

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

NZME Limited (NZX: NZM) NZ Markets Disciplinary Tribunal Censures
Rua Bioscience Limited (NZX: RUA) Announces CCO with Global Pharma Experience
Cannasouth Limited (NZX: CBD) Supply Activity Added to Cannasouth Commercial Licence
Skellerup Holdings Limited (NZX: SKL) Upgrades FY21 Earnings Guidance
Napier Port Holdings Limited (NZX: NPH) 2021 Earnings Guidance Update
Comvita Limited (NZX: CVT) Full Year Guidance Update
Scott Technology Limited (NZX: SCT) Meat Industry Contract Win
PaySauce Limited (NZX: PYS) Quarterly Market Update
NZ Windfarms Limited (NZX: NWF) Agrees a New VVFPA for Q1 2022 to Q3 2022
Harmoney Corp Limited (NZX: HMY) 3Q21 Trading Update